Portage Biotech Files 6-K for April 2024
Ticker: ATON · Form: 6-K · Filed: May 1, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | May 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, corporate-action
TL;DR
Portage Biotech filed a 6-K for April, incorporating into S-8. Nothing major, just housekeeping.
AI Summary
Portage Biotech Inc. filed a Form 6-K on May 1, 2024, for the month ending April 30, 2024. The company, incorporated in the British Virgin Islands, is a pharmaceutical preparations company. This filing is incorporated by reference into their Form S-8 registration statement (File No. 333-275842).
Why It Matters
This filing provides an update on the company's reporting status and incorporates information into an existing registration statement, which can be relevant for investors tracking corporate actions.
Risk Assessment
Risk Level: low — The filing is a routine report of foreign private issuer and does not appear to contain significant new financial or operational information.
Key Numbers
- 20240430 — Report Period End Date (Indicates the end of the reporting period for this 6-K filing.)
- 20240501 — Filing Date (The date the report was officially filed with the SEC.)
Key Players & Entities
- Portage Biotech Inc. (company) — Filer of the report
- 333-275842 (registration_statement_file_number) — Form S-8 file number
- 001-40086 (commission_file_number) — SEC file number for Portage Biotech Inc.
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers which provides information that the issuer would be required to disclose to its security holders or make public pursuant to the laws of its home country or a foreign stock exchange on which it is listed.
What does it mean for this filing to be incorporated by reference into Form S-8?
Incorporation by reference means that the information contained in this 6-K filing is considered part of the registration statement on Form S-8, as if it were physically included within it.
What is the primary business of Portage Biotech Inc. according to the filing?
Portage Biotech Inc. is classified under the Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.
Where is Portage Biotech Inc. incorporated?
Portage Biotech Inc. is incorporated in the British Virgin Islands, with its principal executive offices located in Tortola.
Does this filing indicate any new financial results or material events?
This specific filing (Form 6-K) primarily serves as a report of foreign private issuer information and incorporation by reference. It does not appear to detail new financial results or specific material events beyond its reporting function.
Filing Stats: 471 words · 2 min read · ~2 pages · Grade level 9.1 · Accepted 2024-04-30 18:21:42
Filing Documents
- f6k_043024.htm (6-K) — 10KB
- 0001171843-24-002370.txt ( ) — 11KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: April 30, 2024 PORTAGE BIOTECH INC. By: /s/ Allan Shaw Allan Shaw Chief Financial Officer